Plasminogen activator in granulocyte-macrophage-CSF transgenic mice

J Immunol. 1992 Dec 1;149(11):3678-81.

Abstract

The pattern of expression of urokinase type plasminogen activator (PA) in granulocyte-macrophage-CSF transgenic mice and their normal littermates was studied using RNAse protection assays and a plasminogen-dependent fibrinolytic assay for PA. Urokinase type PA mRNA was expressed at a high level in transgenic peritoneal cells and at a lower level in transgenic eye tissue and spleen, but not in equivalent tissue from the normal mice. Enzymically active PA was detectable in protein extracts from peritoneal cells taken from transgenic mice of less than 8 wk of age (young mice) but not from normals. Paradoxically, extracts from transgenic mice of more than 12 wk of age (old mice) showed little detectable PA activity despite continuing transcription in some mice of this age. The production of PA by peritoneal cells may be responsible for the spontaneous i.p. bleeding which is a feature of the transgenic mice and production in other tissues may help explain the local pathologic changes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Animals
  • Gene Expression
  • Granulocyte-Macrophage Colony-Stimulating Factor / physiology*
  • Mice
  • Mice, Transgenic
  • Peritoneal Cavity / cytology
  • Plasminogen Inactivators / metabolism
  • RNA, Messenger / genetics
  • Urokinase-Type Plasminogen Activator / genetics
  • Urokinase-Type Plasminogen Activator / metabolism*

Substances

  • Plasminogen Inactivators
  • RNA, Messenger
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Urokinase-Type Plasminogen Activator